| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jan―23 |
Evaluating the pandemic potential of Zika virus in a changing global landscape |
Soumba Traore, Sophia C Chima, Kristina M Adams Waldorf, Jennifer Tisoncik-Go, Megan A O’Connor |
| 2 |
[GO] |
2025―Oct―01 |
COVID-19 and inflammatory bowel disease - what to know |
Anne Godat, Dimitrios Chistoforidis, Thomas Greuter |
| 3 |
[GO] |
2025―Sep―23 |
The outcome of severe MIS-C managed at the Italian epicenter of the SARS-CoV-2 epidemic: a follow-up study of 50 consecutive patients |
Lucio Verdoni, Angelo Mazza, Laura Martelli, Annalisa Gervasoni, Angela Amoroso, Simona Anna Marcora, et al. (+4) Paolo Brambilla, Ezio Bonanomi, Greta Carioli, Lorenzo D’Antiga |
| 4 |
[GO] |
2025―Sep―11 |
Skin manifestations of SARS-CoV-2 infection and its vaccination |
Fanny Saidoune, Ahmad Yatim, Jeremy Di Domizio, Michel Gilliet |
| 5 |
[GO] |
2025―Aug―19 |
SARS-CoV-2 and chronic kidney disease: challenges and future directions |
Giannini Olivier, Elzi Luigia |
| 6 |
[GO] |
2025―Jul―19 |
The impact of viral evolution on vaccine development for SARS-CoV-2 |
Martin F Bachmann, Mona O Mohsen, Daniel E Speiser |
| 7 |
[GO] |
2025―May―23 |
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune tolerance |
Antonio Tonutti, Francesca Motta, Natasa Isailovic, Carlo Selmi, Suraj Timilsina, Merrill Eric Gershwin, Maria De Santis |
| 8 |
[GO] |
2025―May―15 |
SARS-CoV-2: lessons in virus mutation prediction and pandemic preparedness |
Weiyi Tang, Jenna Kim, Raphael TC Lee, Sebastian Maurer-Stroh, Laurent Renia, Matthew Z Tay |
| 9 |
[GO] |
2024―Sep―06 |
Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection |
Yunxiang Yang, Alessia Azzuolo, Nassima Fodil, Philippe Gros |
| 10 |
[GO] |
2024―May―24 |
The antiviral state of the cell: lessons from SARS-CoV-2 |
Jérémie Le Pen, Charles M Rice |
| 11 |
[GO] |
2024―May―21 |
Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic |
Sara Svensson Akusjärvi, Ivan Zanoni |
| 12 |
[GO] |
2023―Oct―06 |
The future of vaccination in Latin America: learning from the COVID-19 pandemic |
Fernando E Díaz, Lourdes Arruvito, Jorge Geffner |
| 13 |
[GO] |
2023―Sep―12 |
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation |
Tamara S Rodrigues, Dario S Zamboni |
| 14 |
[GO] |
2023―Aug―29 |
Lessons learned from the successful polio vaccine experience not learned or applied with the development and implementation of the COVID-19 vaccines |
Charles S Pavia, Maria M Plummer |
| 15 |
[GO] |
2022―Sep―28 |
Move and countermove; the integrated stress response in picorna- and coronavirus-infected cells |
Chiara Aloise, Jelle G. Schipper, Raoul J. de Groot, Frank J.M. van Kuppeveld |
| 16 |
[GO] |
2022―Sep―14 |
Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus |
GuanQun Liu, Michaela U. Gack |
| 17 |
[GO] |
2022―May―24 |
Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection |
Krista L Newell, Adam T Waickman |
| 18 |
[GO] |
2022―Apr―20 |
Accelerating clinical trial development in vaccinology: Covid-19 and beyond |
Lawrence Corey, Maurine D. Miner |
| 19 |
[GO] |
2022―Mar―25 |
HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection |
Danillo G. Augusto, Jill A. Hollenbach |
| 20 |
[GO] |
2022―Jan―25 |
Type I interferons and SARS-CoV-2: from cells to organisms |
Paul Bastard, Qian Zhang, Shen-Ying Zhang, Emmanuelle Jouanguy, Jean-Laurent Casanova |
| 21 |
[GO] |
2021―Jul―12 |
COVID-19 vaccines |
Duduzile Ndwandwe, Charles S Wiysonge |
| 22 |
[GO] |
2021―Jun―16 |
The politics of Covid-19 Vaccine Confidence |
Majdi M Sabahelzain, Kenneth Hartigan-Go, Heidi Larson |
